Off-the-shelf CD123 CAR-NK for R/R AML

Clinical trial NCT06201247 · RECRUITING

Trial details

NCT number: NCT06201247
Sponsor: Peking University People's Hospital
Status: RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Acute Myeloid Leukemia, in Relapse Acute Myeloid Leukemia Refractory

Start date: 2023-12-30
Primary completion: 2025-12-30
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.